Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trialsEuropean heart journal, 2021-03, Vol.42 (9), p.896-903 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa1034 ;PMID: 33417682Full text available |
|
2 |
Material Type: Article
|
Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stressJournal of advanced research, 2021-12, Vol.34, p.43-63 [Peer Reviewed Journal]2021 ;2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. ;2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. 2021 ;ISSN: 2090-1232 ;EISSN: 2090-1224 ;DOI: 10.1016/j.jare.2021.06.023 ;PMID: 35024180Full text available |
|
3 |
Material Type: Article
|
Prevalence of statin intolerance: a meta-analysisEuropean heart journal, 2022-09, Vol.43 (34), p.3213-3223 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. 2022 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehac015 ;PMID: 35169843Full text available |
|
4 |
Material Type: Article
|
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisCell, 2015-12, Vol.163 (7), p.1585-1595 [Peer Reviewed Journal]2015 Elsevier Inc. ;Copyright © 2015 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2015.11.055 ;PMID: 26687352Full text available |
|
5 |
Material Type: Article
|
Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus – Mechanisms, Management, and Clinical ConsiderationsCirculation (New York, N.Y.), 2016-06, Vol.133 (24), p.2459-2502 [Peer Reviewed Journal]2016 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2016 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.116.022194 ;PMID: 27297342Full text available |
|
6 |
Material Type: Article
|
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart AssociationArteriosclerosis, thrombosis, and vascular biology, 2022-01, Vol.42 (1), p.e48-e60 [Peer Reviewed Journal]ISSN: 1079-5642 ;EISSN: 1524-4636 ;DOI: 10.1161/atv.0000000000000147 ;PMID: 34647487Full text available |
|
7 |
Material Type: Article
|
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural ProductsPharmacological reviews, 2019-10, Vol.71 (4), p.596-670 [Peer Reviewed Journal]Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics. ;ISSN: 0031-6997 ;EISSN: 1521-0081 ;DOI: 10.1124/pr.118.017178 ;PMID: 31554644Full text available |
|
8 |
Material Type: Article
|
Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosisEuropean heart journal, 2020-08, Vol.41 (31), p.2983-2996 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz919 ;PMID: 31898722Full text available |
|
9 |
Material Type: Article
|
Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restrictionEuropean heart journal, 2020-07, Vol.41 (28), p.2681-2695 [Peer Reviewed Journal]Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019 ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz112 ;PMID: 30903157Full text available |
|
10 |
Material Type: Article
|
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular DiseaseCirculation (New York, N.Y.), 2022-10, Vol.146 (15), p.1109-1119 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.061620 ;PMID: 36031810Full text available |
|
11 |
Material Type: Article
|
Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic PlaqueCirculation (New York, N.Y.), 2020-12, Vol.142 (24), p.2299-2311 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.049981 ;PMID: 33003973Full text available |
|
12 |
Material Type: Article
|
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseThe New England journal of medicine, 2017-09, Vol.377 (12), p.1119-1131 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1707914 ;PMID: 28845751Full text available |
|
13 |
Material Type: Article
|
Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosisNature reviews cardiology, 2022-04, Vol.19 (4), p.228-249 [Peer Reviewed Journal]2021. Springer Nature Limited. ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1759-5002 ;ISSN: 1759-5010 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-021-00629-x ;PMID: 34759324Full text available |
|
14 |
Material Type: Article
|
Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokinesNature communications, 2020-05, Vol.11 (1), p.2622-14, Article 2622 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-16439-7 ;PMID: 32457361Full text available |
|
15 |
Material Type: Article
|
Response by O'Donoghue et al to Letter Regarding Article, "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease"Circulation (New York, N.Y.), 2023-04, Vol.147 (16), p.1258-1259 [Peer Reviewed Journal]ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.123.064048 ;PMID: 37068132Full text available |
|
16 |
Material Type: Article
|
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trialThe Lancet (British edition), 2022-07, Vol.400 (10349), p.380-390 [Peer Reviewed Journal]Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00916-3 ;PMID: 35863366Full text available |
|
17 |
Material Type: Article
|
Rivaroxaban with or without Aspirin in Stable Cardiovascular DiseaseThe New England journal of medicine, 2017-10, Vol.377 (14), p.1319-1330 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709118 ;PMID: 28844192Full text available |
|
18 |
Material Type: Article
|
Inflammatory processes in cardiovascular disease: a route to targeted therapiesNature reviews cardiology, 2017-03, Vol.14 (3), p.133-144 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Mar 2017 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/nrcardio.2016.185 ;PMID: 27905474Full text available |
|
19 |
Material Type: Article
|
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and BeyondJournal of the American College of Cardiology, 2017-10, Vol.70 (18), p.2278-2289 [Peer Reviewed Journal]Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 31, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.09.028 ;PMID: 29073957Full text available |
|
20 |
Material Type: Article
|
2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus DocumentsJournal of the American College of Cardiology, 2016-07, Vol.68 (1), p.92-125 [Peer Reviewed Journal]Copyright Elsevier Limited Jul 5, 2016 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.03.519 ;PMID: 27046161Full text available |